immune system News
-
Tumor immunology expert joining Redbiotec’s SAB
Redbiotec is pleased to welcome Prof. Maries van den Broek, PhD, Professor at the University of Zurich, Institute of Experimental Immunology, as an additional exclusive member of our Scientific Advisory Board. Maries is a renowned expert in the field of tumor immunology. The aim of her work is to better understand the mutual interaction between the immune system and cancer. Redbiotec looks ...
By Redbiotec AG
-
BioTech Breakthrough Recognizes Ozette as the 2022 Overall Immunology Company of the Year
We’re honored to be named the 2022 Overall Immunology Company of the Year by BioTech Breakthrough. Ozette’s computational immune profiling tech breaks through complex, highly dimensional datasets to revolutionize our understanding of the human immune system. BioTech Breakthrough recognizes Ozette for accelerating scientific collaboration with automated and interpretable single-cell ...
-
MiLaboratories LLC launches TCR profiling for non-human primates
Service available for rhesus macaque (Macaca mulatta) and cynomolgus (crab-eating macaque, Macaca fascicularis). Phylogenetic closeness to humans makes non-human primates a model of choice for assessing the safety and efficiency of novel monoclonal antibodies and immunotherapeutic approaches. UMI-based TCR profiling allows to track the clonotype fates and alterations in TCR repertoire with the ...
-
Recent Success Combining Single Cell Sequencing with AI/Advanced Analytics
Single cell sequencing has transformed our ability to discern the cellular and molecular makeup of human immune systems and tissues. The size and complexity of the data sets generated requires the application of advanced analytics and artificial intelligence to reveal the signal contained within. The marriage of scRNAseq + AI has been shown to identify rare cell populations/subtypes and provide ...
-
Fungal Infections and the CDC’s 10 Questions to Protect Your Health Discussed in New Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses the Centers for Disease Control and Prevention’s list of ten questions to help people learn their chances of developing a fungal infection. “The CDC states that only about 300 out of 1.5 million different species of fungi are known to ...
-
Immunai acquires single-cell data developer Dropprint Genomics to build out its immune system atlas
Shortly after raising $60 million to fuel its artificial intelligence work, aimed at digitally charting the human body’s immune system, Immunai announced it has acquired the single-cell sequencing software startup Dropprint Genomics. Previously backed by Y Combinator, the San Francisco-based Dropprint aims to provide big data and machine learning solutions to help crunch the numbers ...
By Immunai
-
Healthcare Facilities need to be Aware of Microbial Pathogens
Countless people live productive and fulfilling lives with immune systems that are weakened due to inherited genetic defects, physical conditions, illnesses, past medical procedures or because of prescription drugs taken for various reasons. These individuals need to be especially aware of common microbial pathogens that are often found all around us. These pathogens may include various ...
-
Single Cell Sequencing: Transform Your Immunology and Cancer Research from Bulk to Single Cell Analysis
Single cell sequencing has transformed our ability to discern the cellular and molecular makeup of human immune systems and tissues in a unique manner with a level of precision that other “omic” technologies are unable to provide. Coupled with rigorous analysis, this technology is able to identify rare cell populations/subtypes and provide novel insights about pathways and thus ...
-
Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform
Immunai, a New York-based biotech company, today announced a $215M Series B, increasing the company’s total funding to date to $295M. The new capital will be used to expand Immunai’s “drug actuary” platform for target validation and evaluation. “We have made great progress towards our core mission of understanding the immune system, which we believe is essential to ...
By Immunai
-
Fermented Foods such as Kombucha are Trendy, but They’re Not Necessarily Probiotics
Fermentation is a case of what’s old is new again — an ancient food-processing method turned hot trend, with companies churning out products incorporating kefir, kimchi, sauerkraut and kombucha that are promoted as being probiotics. But do these foods offer true probiotic benefits? The short answer is probably not. But that doesn’t mean these foods are without benefit. First, ...
-
Does noise pollution weaken the immune system?
Excess noise is a common cause of stress and its impact on health is a concern for environmental policy makers. An analysis of current research in this area raises the question of whether noise-induced stress could increase the likelihood of illness by weakening the immune system. The European Noise Directive1 requires Member States to draw up strategic noise maps to show the level of noise in ...
-
Immunai Recognized by Fast Company’s 2021 World Changing Ideas Awards
Immunai, a New York and Tel Aviv-based biotech company, today announced that it has been recognized as part of Fast Company’s World Changing Ideas Awards. The awards honor the businesses, policies, projects, and concepts that are actively engaged and deeply committed to pursuing innovation when it comes to solving health and climate crises, social injustice, or economic inequality. Immunai ...
By Immunai
-
Hundreds of lives saved through new technology to spot sepsis
The NHS has saved hundreds of people from sepsis thanks to better use of digital technology in hospitals. In a major nationwide push to tackle the condition, including a one hour identification and treatment ambition, new ‘alert and action’ technology is being introduced which uses algorithms to read patients’ vital signs and alert medics to worsening conditions that are a ...
-
Rugged reliability for active lifestyles
Walking, kayaking, swimming—if it’s happening outside, 39-year-old Cortney Small of Crimora, Virginia, is all in. It makes perfect sense, since she is something of a force of nature herself: After illness and infection threatened her life repeatedly, she’s fought her way back to live life to the full…and nothing’s going to hem her in. “I was diagnosed with ...
-
Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb
Prellis Biologics, Inc. (Prellis), a Bay Area biotechnology company, announced today that it has entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb utilizing Prellis Biologics’ first-in-class externalized human immune system (EXIS) based on human lymph node organoids (LNO). The collaboration leverages Prellis’ EXIS platform that ...
-
Nature communications. ATP released by intestinal bacteria limits…
T cell dependent secretory IgA (SIgA) generated in the Peyer’s patches (PPs) of the small intestine shapes a broadly diverse microbiota that is crucial for host physiology. The mutualistic co-evolution of host and microbes led to the relative tolerance of host’s immune system towards commensal microorganisms. The ATP-gated ionotropic P2X7 receptor limits T follicular helper (Tfh) ...
-
Deadly Fungal Pathogen Appears to be Developing Drug Resistance
Clinical Infectious Diseases recently published a study that discovered azole-resistance markers in 75% of a small group of aspergillosis patients who had not previously been treated with an azole. Although the study group was small, the findings appear to indicate that there is a growing dissemination of drug-resistant strains of Aspergillus fungi. Azole antifungal agents are a common option ...
-
Toxoplasmosis Exposed in New Online Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of another online video to help educate the public about issues that may impact their health. The latest educational video discusses the threat to human health due to Toxoplasmosis and Toxoplasma gondii. Toxoplasmosis is a disease caused by a single-celled parasite called Toxoplasma gondii. More than 60 million ...
-
Immunai Launches to Fully Map the Entire Immune System to Better Develop Immunotherapies and Cell Therapies
Today, Immunai launches out of stealth to map the entire immune system for better detection, diagnosis, and treatment of disease. Leveraging single-cell technologies and machine learning algorithms, Immunai has mapped out millions of immune cells and their functions, building the largest proprietary data set in the world for clinical immunological data. The company is also announcing $20M in seed ...
By Immunai
-
Immunai Raises $60M to Reprogram Immunity
Immunai, a New York and Tel Aviv based biotech company, announced today $60M in funding, increasing the company’s total funding-to-date to over $80M. Immunai integrates multi-omic single-cell analytics and machine learning to identify novel immunological insights that lead to the discovery and development of more effective and targeted immunotherapies. The Series A round was led by ...
By Immunai
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you